Role of gamma interferon in a neonatal mouse model of group B streptococcal disease.
AUTOR(ES)
Cusumano, V
RESUMO
The aim of this study was to assess the role of gamma interferon (IFN-gamma) in a neonatal mouse model of group B streptococcal (GBS) sepsis. IFN-gamma was produced by spleen cells at 24, 48, and 72 h after GBS challenge. Treatment with anti-IFN-gamma at 6 h before challenge totally abrogated the IFN-gamma response but did not affect survival. Subcutaneous administration of recombinant IFN-gamma (2,500 IU per pup) at 18 h after challenge resulted in increased survival time and reduced blood colony counts at 48 and 72 h. In vitro preincubation of neonatal whole blood with IFN-gamma before the addition of GBS resulted in significant restriction of bacterial growth. These data indicate that administration of recombinant IFN-gamma can partially restore impaired host defenses against GBS in neonatal mice. This cytokine may be useful for the treatment of neonatal infections.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174171Documentos Relacionados
- Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease.
- Role of Streptococcal Pyrogenic Exotoxin B in the Mouse Model of Group A Streptococcal Infection
- Role of Streptolysin O in a Mouse Model of Invasive Group A Streptococcal Disease
- Adult mice as a model for early onset group B streptococcal disease.
- Role of Adherence in the Pathogenesis of Neonatal Group B Streptococcal Infection
